1Life Healthcare Inc. (ONEM) Chief Financial Officer Owns Stock Worth $6116.0


1Life Healthcare Inc. (NASDAQ:ONEM) traded with an addition of $0.09 to close at $16.79 on Thursday, an upside of 0.54 percent. An average of 994,889 shares of common stock have been traded in the last five days. There was a fall of -$0.11 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 2,268,307 shares traded, while the 50-day average volume stands at 2,651,989.

ONEM stock has decreased by -0.36% in the last month. The company shares reached their 1-month lowest point of $16.55 on 12/06/22. With the stock rallying to its 52-week high on 01/04/22, shares of the company touched a low of $5.94 and a high of $18.43 in 52 weeks. It has reached a new high 2 times so far this year and lost -4.95% or -$0.79 in price. In spite of this, the price is down -8.90% from the 52-week high.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Insider Transactions

ONEM stock investors should be aware that 1Life Healthcare Inc. (ONEM) stock had its last reported insider trading activity 9 days ago on Dec 20. In this transaction, the insider spent $102,238. Chief Financial Officer, Thaler Bjorn B, disposed of 200 shares at a price of $17.00 on Dec 01. The insider now owns more than $3,400 worth of shares. Prior to that, General Counsel and Secretary Mango Lisa A went on to Sale 4,102 shares at $16.58 each on Nov 21. An amount of $68,019 was transacted.

Valuation Metrics

1Life Healthcare Inc. (ONEM) has a trailing price-to-sales (P/S) ratio at 3.41, the price-to-book (PB) ratio at 2.10.

Financial Health

The quick ratio of 1Life Healthcare Inc. for the three months ended September 29 was 2.10, and the current ratio was 2.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.20 and a total debt to equity ratio of 0.20 for the quarter ending September 29. Its gross profit as reported stood at $188.13 million compared to revenue of $623.32 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, 1Life Healthcare Inc.’s return on assets was -15.30%.

Earnings Surprise

For the three-month period that ended September 29, 1Life Healthcare Inc. had $127.7 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$112.04 million in the quarter, while revenues of -$93.81 million were grew 29.85%. The analyst consensus anticipated 1Life Healthcare Inc.’s latest quarter earnings to come in at -$0.46 per share, but it turned out to be -$0.57, a -23.90% surprise. For the quarter, EBITDA amounted to -$84.61 million. Shareholders own equity worth $204.35 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at 1Life Healthcare Inc. (ONEM) price momentum. RSI 9-day as of the close on 28 December was 50.53%, suggesting the stock is Neutral, with historical volatility in this time frame at 11.52%.

As of today, ONEM’s price is $16.72 -0.65% or -$0.11 from its 5-day moving average. ONEM is currently trading -1.24% lower than its 20-day SMA and -0.36% lower than its 100-day SMA. However, the stock’s current price level is -1.76% below the SMA50 and +109.49% above the SMA200.

The stochastic %K and %D were 29.02% and 30.20%, respectively, and the average true range (ATR) was 0.16. With the 14-day stochastic at 46.34% and the average true range at 0.15, the RSI (14) stands at 49.47%. The stock has reached -0.07 on the 9-day MACD Oscillator while the 14-day reading was at -0.10.

Analyst Ratings

Deutsche Bank downgraded 1Life Healthcare Inc. (NASDAQ: ONEM) to a a Hold rating in its most recent analyst report. Previously, the stock was rated as a Buy.

What is ONEM’s price target for the next 12 months?

Analysts predict a range of price targets between $18.00 and $18.00, with a median target of $18.00. Taking a look at these predictions, the average price target given by analysts for 1Life Healthcare Inc. (ONEM) stock is $18.00.


Please enter your comment!
Please enter your name here